{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:54:35Z","timestamp":1778651675201,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2019,9,1]]},"DOI":"10.1007\/s13555-019-0303-4","type":"journal-article","created":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T12:02:41Z","timestamp":1559649761000},"page":"505-510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test"],"prefix":"10.1007","volume":"9","author":[{"given":"Alessia","family":"Villani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Fabbrocini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Cappello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Scalvenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,4]]},"reference":[{"issue":"1","key":"303_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/ajd.12205","volume":"56","author":"C Gaulin","year":"2015","unstructured":"Gaulin C, Sebaratnam DF, Fern\u00e1ndez-Pe\u00f1as P. Quality of life in non-melanoma skin cancer. Australas J Dermatol. 2015;56(1):70\u20136.","journal-title":"Australas J Dermatol."},{"key":"303_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s13187-018-1368-y","author":"R Abedini","year":"2018","unstructured":"Abedini R, Nasimi M, Noormohammad Pour P, Moghtadaie A, Tohidinik HR. Quality of life in patients with non-melanoma skin cancer: implications for healthcare education services and supports. J Cancer Educ. 2018. https:\/\/doi.org\/10.1007\/s13187-018-1368-y.","journal-title":"J Cancer Educ."},{"issue":"6","key":"303_CR3","doi-asserted-by":"publisher","first-page":"758","DOI":"10.4103\/ijdvl.IJDVL_92_18","volume":"84","author":"M Scalvenzi","year":"2018","unstructured":"Scalvenzi M, Villani A, Mazzella C, Cappello M, Salvatores GF, Costa C. Vismodegib treatment in a HIV positive patient on antiretroviraltherapy. Indian J Dermatol Venereol Leprol. 2018;84(6):758\u201360.","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"303_CR4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ejca.2017.08.022","volume":"86","author":"N Basset-S\u00e9guin","year":"2017","unstructured":"Basset-S\u00e9guin N, Hauschild A, Kunstfeld R, et al. Vismodegib in patients with advanced basal cell carcinoma: primary analysis of STEVIE, an international, open-label trial. Eur J Cancer. 2017;86:334\u201348.","journal-title":"Eur J Cancer."},{"issue":"7","key":"303_CR5","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1097\/00042728-200607000-00010","volume":"32","author":"BA Matthews","year":"2006","unstructured":"Matthews BA, Rhee JS, Neuburg M, Burzynski ML, Nattinger AB. Development of the facial skin care index: a health-related outcomes index for skin cancer patients. Dermatol Surg. 2006;32(7):924\u201334.","journal-title":"Dermatol Surg"},{"issue":"3","key":"303_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210\u20136.","journal-title":"Clin Exp Dermatol"},{"key":"303_CR7","doi-asserted-by":"crossref","unstructured":"Girardi D, Barrichello A, Fernandes G, Pereira A. Targeting the Hedgehog pathway in cancer: current evidence and future perspectives. Cells. 2019;8(2):E153.","DOI":"10.3390\/cells8020153"},{"issue":"2","key":"303_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2217\/fon-2016-0296","volume":"13","author":"K Fife","year":"2017","unstructured":"Fife K, Herd R, Lalondrelle S, et al. Managing adverse events associated with vismodegib in the treatment of basal cell carcinoma. Future Oncol. 2017;13(2):175\u201384.","journal-title":"Future Oncol."},{"key":"303_CR9","doi-asserted-by":"crossref","unstructured":"Woltsche N, Pichler N, Wolf I, Di Meo N, Zalaudek I. Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the Hedgehog inhibitor vismodegib: a single centre experience. J Eur Acad Dermatol Venereol. 2019;33(4):e144\u20135.","DOI":"10.1111\/jdv.15367"},{"key":"303_CR10","doi-asserted-by":"crossref","unstructured":"Scalvenzi M, Costa C, Cappello M, Villani A. Reply to Woltsche N. et al. Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the Hedgehog inhibitor vismodegib: a single center experience. J Eur Acad Dermatol Venereol. 2019;33(4):e145\u20137.","DOI":"10.1111\/jdv.15469"},{"key":"303_CR11","doi-asserted-by":"crossref","unstructured":"Matthews BA, Rhee JS, Neuburg M, Burzynski ML, Nattinger AB. Development\u00a0of the\u00a0facial\u00a0skin care\u00a0index: a\u00a0health-related\u00a0outcomes\u00a0index\u00a0for\u00a0skin cancer patients. Dermatol Surg. 2006;32(7):924\u201334 (discussion 934).","DOI":"10.1097\/00042728-200607000-00010"},{"issue":"2","key":"303_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1087-0024.2004.09113.x","volume":"9","author":"V Lewis","year":"2004","unstructured":"Lewis V, Finlay AY. 10\u00a0years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol. 2004;9(2):169\u201380.","journal-title":"J Investig Dermatol."},{"issue":"2","key":"303_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/BF00434740","volume":"5","author":"S Blackford","year":"1996","unstructured":"Blackford S, Roberts D, Salek MS, Finlay A. Basal cell carcinomas cause little handicap. Qual Life Res. 1996;5(2):191\u20134.","journal-title":"Qual Life Res"},{"issue":"4 Pt 1","key":"303_CR14","first-page":"525","volume":"30","author":"JS Rhee","year":"2004","unstructured":"Rhee JS, Matthews BA, Neuburg M, Smith TL, Burzynski M, Nattinger AB. Skin cancer and quality of life: assessment with the dermatology life quality index. Dermatol Surg. 2004;30(4 Pt 1):525\u20139.","journal-title":"Dermatol Surg"},{"key":"303_CR15","doi-asserted-by":"crossref","unstructured":"Skiveren J, Mikkelsen MR, Daugbjerg H, Wulf HC. Skin\u00a0reactions\u00a0and\u00a0quality\u00a0of\u00a0life\u00a0after\u00a0X-ray\u00a0therapy\u00a0of\u00a0basal\u00a0cell\u00a0carcinoma. J Skin Cancer. 2012;2012:825095.","DOI":"10.1155\/2012\/825095"},{"issue":"6","key":"303_CR16","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1684\/ejd.2018.3448","volume":"28","author":"J Hansson","year":"2018","unstructured":"Hansson J, Bartley K, Karagiannis T, et al. Assessment of\u00a0quality of life\u00a0using Skindex-16 in patients with advanced basal cell carcinoma treated with\u00a0vismodegib\u00a0in the STEVIE study. Eur J Dermatol. 2018;28(6):775\u201383.","journal-title":"Eur J Dermatol."},{"key":"303_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17754","author":"G Gualdi","year":"2019","unstructured":"Gualdi G, Moro R, Regina V, Caravello S, Monari P, Calzavara-Pinton PG. PRISModegib: the use of the PRISM test to assess the health-related quality of life of patients with locally advanced basal cell carcinoma undergoing Hedgehog pathway inhibitor therapy. Br J Dermatol. 2019. https:\/\/doi.org\/10.1111\/bjd.17754.","journal-title":"Br J Dermatol."},{"issue":"1","key":"303_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1365-2133.2005.06959.x","volume":"154","author":"M Shah","year":"2006","unstructured":"Shah M, Coates M. An\u00a0assessment\u00a0of the\u00a0quality of life\u00a0in\u00a0older\u00a0patients\u00a0with\u00a0skin disease. Br J Dermatol. 2006;154(1):150\u20133.","journal-title":"Br J Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-019-0303-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-019-0303-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-019-0303-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T20:56:10Z","timestamp":1710363370000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-019-0303-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,4]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9,1]]}},"alternative-id":["303"],"URL":"https:\/\/doi.org\/10.1007\/s13555-019-0303-4","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,4]]},"assertion":[{"value":"8 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}